VERTEX PHARMACEUTICALS INC / MA reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
VERTEX PHARMACEUTICALS INC / MA has filed 3,632 SEC EDGAR filings since 15 Feb 1995

SEC filing history

Showing 601-625 of 1,000 matching filings.

Per page
25
Current page
25
4

FORM 4 SUBMISSION

Filing date
03 May 2023
Reporting date
01 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 May 2023
Reporting date
01 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
03 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
02 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
02 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
02 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 May 2023
Reporting date
27 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
27 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Apr 2023
Reporting date
14 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Apr 2023
Reporting date
14 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Apr 2023
Reporting date
12 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Apr 2023
Reporting date
12 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
12 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
12 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 000-19319

VERTEX PHARMACEUTICALS INC - ARS

Filing date
06 Apr 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-19319

VERTEX PHARMACEUTICALS INC - DEFA14A

Filing date
06 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-19319

VERTEX PHARMACEUTICALS INC - DEF 14A

Filing date
06 Apr 2023
Reporting date
Not listed
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Apr 2023
Reporting date
04 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
04 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2023
Reporting date
31 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2023
Reporting date
31 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Mar 2023
Reporting date
24 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
24 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .